US Patent Issued to Theralase Technologies on Sept. 1 for "Inactivation of pathogens using metal-based coordination complexes, and methods and compositions for treating and preventing microbial and/or viral infections" (Canadian Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,854, issued on Sept. 1, was assigned to Theralase Technologies Inc. (Toronto).

"Inactivation of pathogens using metal-based coordination complexes, and methods and compositions for treating and preventing microbial and/or viral infections" was invented by Roger Dumoulin-White (Toronto) and Arkady Mandel (North York, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for eliciting an immune response in a patient includes the sequential steps of: providing an immunogenic composition including an immunogen; adding a metal-based coordination complex to the immunogenic composition to inactivate or attenuate the immunogen; and administering th...